ZAGNI, CHIARA

ZAGNI, CHIARA  

SCIENZE DEL FARMACO E DELLA SALUTE (DSFS) (Department of Drug and Health Sciences)  

Mostra records
Risultati 1 - 20 di 37 (tempo di esecuzione: 0.026 secondi).
Titolo Data di pubblicazione Autore(i) File
1,2-Dibenzoylhydrazine as a Multi-Inhibitor Compound: A Morphological and Docking Study 1-gen-2023 Patamia, Vincenzo; Floresta, Giuseppe; Zagni, Chiara; Pistara', Venerando; Punzo, Francesco; Rescifina, Antonio file da validare
3D-QSAR assisted identification of FABP4 inhibitors: An effective scaffold hopping analysis/QSAR evaluation 1-gen-2019 Floresta, G.; Cilibrizzi, A.; Abbate, V.; Spampinato, A.; Zagni, C.; Rescifina, A.
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. An update from 2017 to early 2022 1-gen-2022 Floresta, G.; Patamia, V.; Zagni, C.; Rescifina, A. file da validare
An alpha1-adrenergic receptor ligand repurposed as a potent antiproliferative agent for head and neck squamous cell carcinoma 1-gen-2015 Zagni, C; Guimarães, Dm; Salerno, Loredana; Punzo, Francesco; Squarize, Ch; Mineo, Placido; Romeo, Giuseppe; Rescifina, Antonio
Artificial Intelligence Technologies for COVID-19 De Novo Drug Design 1-gen-2022 Floresta, G.; Zagni, C.; Gentile, D.; Patamia, V.; Rescifina, A. file da validare
Carbamoyl-Decorated Cyclodextrins for Carbon Dioxide Adsorption 1-gen-2023 Patamia, Vincenzo; Tomarchio, Rosario; Fiorenza, Roberto; Zagni, Chiara; Scire', Salvatore; Floresta, Giuseppe; Rescifina, Antonio file da validare
Computer-Assisted Design of Peptide-Based Radiotracers 1-gen-2023 Patamia, Vincenzo; Zagni, Chiara; Brullo, Ilaria; Saccullo, Erika; Coco, Alessandro; Floresta, Giuseppe; Rescifina, Antonio file da validare
Design, synthesis, in vitro evaluation, and molecular modeling studies of N-substituted benzomorphans, analogs of LP2, as novel MOR ligands 1-gen-2023 Costanzo, Giuliana; Patamia, Vincenzo; Turnaturi, Rita; Parenti, Carmela; Zagni, Chiara; Lombino, Jessica; Amata, Emanuele; Marrazzo, Agostino; Pasquinucci, Lorella; Rescifina, Antonio
Discovery of first novel sigma/HDACi dual-ligands with a potent in vitro antiproliferative activity 1-gen-2023 Barbaraci, Carla; di Giacomo, Viviana; Maruca, Annalisa; Patamia, Vincenzo; Rocca, Roberta; Dichiara, Maria; Di Rienzo, Annalisa; Cacciatore, Ivana; Cataldi, Amelia; Balaha, Marwa; Rapino, Monica; Zagni, Chiara; Zampieri, Daniele; Pasquinucci, Lorella; Parenti, Carmela; Amata, Emanuele; Rescifina, Antonio; Alcaro, Stefano; Marrazzo, Agostino file da validare
DNA intercalators based on (1,10-phenanthrolin-2-yl)isoxazolidin-5-yl core with better growth inhibition and selectivity than cisplatin upon head and neck squamous cells carcinoma 1-gen-2018 Varrica G., Maria; Zagni, Chiara; Mineo, Placido; Floresta, Giuseppe; Monciino, Giulia; Pistara, Venerando; Abbadessa, Antonio; Nicosia, Angelo; Castilho M., Rogerio; Amata, Emanuele; Rescifina, Antonio
DNA Recognition with Polycyclic-Aromatic-Hydrocarbon-Presenting Calixarene Conjugates 1-gen-2014 Rescifina, Antonio; Zagni, C; Mineo, Placido; Giofrè, S; Chiacchio, Ugo; Tommasone, S; Talotta, C; Gaeta, C; Neri, P.
FABP4 inhibitors 3D-QSAR model and isosteric replacement of BMS309403 datasets 1-gen-2019 Floresta, G.; Cilibrizzi, A.; Abbate, V.; Spampinato, A.; Zagni, C.; Rescifina, A.
HEMA-based macro and microporous materials for CO2 capture 1-gen-2023 Zagni, C.; Coco, A.; Dattilo, S.; Patamia, V.; Floresta, G.; Fiorenza, R.; Curcuruto, G.; Mecca, T.; Rescifina, A.
Heparan Sulfate and Enoxaparin Interact at the Interface of the Spike Protein of HCoV-229E but Not with HCoV-OC43 1-gen-2023 Fuochi, Virginia; Floresta, Giuseppe; Emma, Rosalia; Patamia, Vincenzo; Caruso, Massimo; Zagni, Chiara; Ronchi, Federica; Ronchi, Celestino; Drago, Filippo; Rescifina, Antonio; Furneri, Pio Maria
Histone Methyltransferase Inhibitors: Novel Epigenetic Agents for Cancer Treatment 1-gen-2013 Zagni, C.; Chiacchio, Ugo; Rescifina, Antonio
How can artificial intelligence be utilized for de novo drug design against COVID-19 (SARS-CoV-2)? 1-gen-2023 Floresta, Giuseppe; Zagni, Chiara; Patamia, Vincenzo; Rescifina, Antonio file da validare
Hydroxamic Acid-Based Histone Deacetylase (HDAC) inhibitors bearing a pyrazole scaffold and a cinnamoyl linker 1-gen-2019 Zagni, C.; Citarella, A.; Oussama, M.; Rescifina, A.; Maugeri, A.; Navarra, M.; Scala, A.; Piperno, A.; Micale, N.
Intramolecular oxidative palladium-​catalyzed diamination reactions of alkenyl sulfamates: an efficient synthesis of [1,​2,​5]​thiadiazolo-​fused piperazinones 1-gen-2016 Chiacchio, U; Broggini, G; Romeo, R; Gazzola, S; Giofre, S; Gabriele, B; Mancuso, R; Floresta, G; Zagni, C; Chiacchio, M
Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2H)-one as Novel Scaffold for FABP4 Inhibition 1-gen-2022 Crocetti, Letizia; Floresta, Giuseppe; Zagni, Chiara; Merugu, Divya; Mazzacuva, Francesca; Rodrigues de Oliveira Silva, Renan; Vergelli, Claudia; Paola Giovannoni, Maria; Cilibrizzi, Agostino
NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC) 1-gen-2014 Almeida, L. O.; Abrahao, A. C.; Rosselli-Murai, L. K.; Giudice, F. S.; Zagni, C.; Leopoldino, A. M.; Squarize, C. H.; Castilho, R. M. file da validare